MX9800944A - Uso de derivados de 1h-1,2,4-triazol para inhibir el crecimiento de canceres. - Google Patents

Uso de derivados de 1h-1,2,4-triazol para inhibir el crecimiento de canceres.

Info

Publication number
MX9800944A
MX9800944A MX9800944A MX9800944A MX9800944A MX 9800944 A MX9800944 A MX 9800944A MX 9800944 A MX9800944 A MX 9800944A MX 9800944 A MX9800944 A MX 9800944A MX 9800944 A MX9800944 A MX 9800944A
Authority
MX
Mexico
Prior art keywords
cancers
growth
inhibiting
triazole derivatives
potentiators
Prior art date
Application number
MX9800944A
Other languages
English (en)
Other versions
MXPA98000944A (es
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MXPA98000944A publication Critical patent/MXPA98000944A/es
Publication of MX9800944A publication Critical patent/MX9800944A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una composicion farmacéutica que inhibe el crecimiento de tumores y cánceres en mamíferos que comprende un derivado de 1H-1,2,4-triazol junto con una cantidad segura y efectiva de un agente quimioterapéutico. Se pueden usar potenciadores para mejorar la efectividad de los fármacos. Los compuestos de triazol y potenciadores también se puede usar para tratar infecciones virales.
MX9800944A 1995-08-03 1996-07-30 Uso de derivados de 1h-1,2,4-triazol para inhibir el crecimiento de canceres. MX9800944A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US183895P 1995-08-03 1995-08-03
US001838 1995-08-03
US08/674,182 US6200992B1 (en) 1995-06-07 1996-07-16 Pharmaceutical composition for inhibiting the growth of cancers
US08674182 1996-07-16
PCT/US1996/012473 WO1997005872A2 (en) 1995-08-03 1996-07-30 Use of 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers

Publications (2)

Publication Number Publication Date
MXPA98000944A MXPA98000944A (es) 1998-04-01
MX9800944A true MX9800944A (es) 1998-04-30

Family

ID=26669546

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9800944A MX9800944A (es) 1995-08-03 1996-07-30 Uso de derivados de 1h-1,2,4-triazol para inhibir el crecimiento de canceres.

Country Status (17)

Country Link
US (3) US6200992B1 (es)
EP (1) EP0841920A2 (es)
JP (1) JPH11510186A (es)
KR (1) KR19990036136A (es)
CN (1) CN1192142A (es)
AR (1) AR003174A1 (es)
AU (1) AU709007B2 (es)
BR (1) BR9609987A (es)
CA (1) CA2228502A1 (es)
CZ (1) CZ30698A3 (es)
IL (1) IL123093A0 (es)
MX (1) MX9800944A (es)
NO (1) NO980419L (es)
PL (1) PL324888A1 (es)
SK (1) SK14098A3 (es)
TR (1) TR199800245T2 (es)
WO (1) WO1997005872A2 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) * 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) * 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
BR0114713A (pt) * 2000-10-16 2004-01-13 Neopharm Inc Formulação lipossÈmica de mitoxantrona
CN1311872C (zh) * 2004-12-29 2007-04-25 山东蓝金生物工程有限公司 一种抗癌药物组合物
US8722014B2 (en) 2009-05-01 2014-05-13 Washington University 1 H-[1, 2, 3] triazole substituted amino acids and uses thereof
WO2012062044A1 (zh) * 2010-11-12 2012-05-18 Yao Xuebiao 动点马达蛋白cenp-e小分子抑制剂syntelin及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079062A (en) 1974-11-18 1978-03-14 Janssen Pharmaceutica N.V. Triazole derivatives
US4160838A (en) 1977-06-02 1979-07-10 Janssen Pharmaceutica N.V. Antimicrobial and plant-growth-regulating triazole derivatives
GB2078719B (en) 1980-06-02 1984-04-26 Ici Ltd Heterocyclic compounds
DE3262386D1 (en) 1981-06-06 1985-03-28 Pfizer Ltd Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them
US4490540A (en) 1981-09-14 1984-12-25 Janssen Pharmaceutica N.V. (2-Aryl-4-phenylthioalkyl-1,3-dioxolan-2-ylmethyl)azole derivatives
EP0196855A3 (en) 1985-03-29 1989-04-12 Pfizer Inc. Tioconazole and related compounds for prevention of sexually transmitted diseases and control of herpetic infections
US5211736A (en) 1988-05-09 1993-05-18 Uniroyal Chemical Company, Inc. Azole derivatives of spiroheterocycles
DE3837463A1 (de) 1988-11-04 1990-05-10 Bayer Ag Substituierte bisazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US5114951A (en) 1989-04-11 1992-05-19 Burroughs Wellcome Company Agents for combating multiple drug resistance
BE1004029A6 (nl) 1990-11-22 1992-09-08 Mol Omer De Farmaceutische samenstelling en farmaceutische set voor het behandelen van kanker.
US5360612A (en) 1992-10-13 1994-11-01 Pfizer Inc. Pharmaceutical compositions containing triazole derivatives for rectal administration
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers

Also Published As

Publication number Publication date
CZ30698A3 (cs) 1998-06-17
SK14098A3 (en) 1998-09-09
KR19990036136A (ko) 1999-05-25
JPH11510186A (ja) 1999-09-07
US6200992B1 (en) 2001-03-13
WO1997005872A3 (en) 1997-03-27
AU6683296A (en) 1997-03-05
PL324888A1 (en) 1998-06-22
EP0841920A2 (en) 1998-05-20
BR9609987A (pt) 1999-01-12
IL123093A0 (en) 1998-09-24
TR199800245T2 (xx) 1998-10-21
CA2228502A1 (en) 1997-02-20
NO980419L (no) 1998-04-02
US6110953A (en) 2000-08-29
NO980419D0 (no) 1998-01-30
CN1192142A (zh) 1998-09-02
AR003174A1 (es) 1998-07-08
AU709007B2 (en) 1999-08-19
US20010047015A1 (en) 2001-11-29
WO1997005872A2 (en) 1997-02-20

Similar Documents

Publication Publication Date Title
MX9800944A (es) Uso de derivados de 1h-1,2,4-triazol para inhibir el crecimiento de canceres.
MX9800998A (es) Uso de fluconazol para inhibir el crecimiento de canceres.
MY116478A (en) Tri-substituted imidazoles having multiple therapeutic properties
RU93051543A (ru) Производные акридина, способ получения, фармацевтическая композиция и способ лечения злокачественных опухолей
IL100942A0 (en) 2,4-diaminoquinazoline derivatives for enhancing antitumor activity
MX9800945A (es) Uso de griseofulvina para inhibir el crecimiento de canceres.
TR199701147T1 (xx) Kanserlerin geli�mesini �nlemeye mahsus, benzimidazol i�eren bir farmas�tik bile�im.
IL99917A0 (en) Indole-and benzimidazole-substituted imidazole and benzimidazole derivatives and pharmaceutical compositions containing the same
NZ308391A (en) Use of 1,2,4-triazole derivatives for the manufacture of a medicament for the treatment of cancers
PL322776A1 (en) Pharmaceutic agent containing n-chlorophenyl carbaminates, n-chlorophenyl thiocarbaminates and derivatives of n-phosphoglycine for inhibiting devlopment of viruses and carcinoma with mammals
PL322732A1 (en) Pharmaceutic agent containing n-chlorophenyl carbaminates and n-chlorophenyl thiocarbaminates for inhibiting development of viruses and carcinoma
JPS5735516A (en) Agent for increasing radiosensitivity or agent for increasing effect of substance having activity similar to radiation
EP0567613A4 (en) Compositions and methods for therapy and prevention of cancer, aids, and anemia
DE3568275D1 (en) Aromatase inhibiting 1,2,3-triazol-1-yl, tetrazol-1-yl, and tetrazol-2-yl compounds
IL68945A0 (en) Bis-triazole derivatives,their preparation and pharmaceutical compositions containing them
DE3565403D1 (en) Imidazolyl, triazolyl, and tetrazolyl compounds
GB9509888D0 (en) Terpenoidic derivatives useful as antitumour agents
HU9301756D0 (en) (2-aryl-substituted)-ethyl-1,2,4-triazoles of fungicidal effect
AU3600199A (en) A pharmaceutical composition containing ezrin mutated on tyrosine 353
IL104775A (en) Pharmaceutical composition containing triazine derivatives for treating pain or oedema
MX9707808A (es) Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres.
MY133682A (en) Substituted pyrroles
HUP9802536A3 (en) Pharmaceutical compositions containing 1,2,4-benzotriazine 1,4-dioxide and use thereof for the preparation of pharmaceutical compositions treating cancer
MX9709712A (es) Uso de derivados de 1,2,4-triazol para la manufactura de un medicamento para el tratamiento de canceres.
MX9709530A (es) Uso de bis-1,2.4-triazoles para la manufactura de un medicamento para el tratamiento de canceres.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal